Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|10|8|840-848

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.8, 2010-12, pp. : 840-848

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Targeting of Apoptosis Pathways for Prostate Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 4, Iss. 1, 2004-02 ,pp. : 85-95

Bentham Science Publishers

Access to resources Recommend Favorite

Signaling Through RAS-RAF-MEK-ERK: from Basics to Bedside

By  

Current Medicinal Chemistry, Vol. 14, Iss. 5, 2007-02 ,pp. : 601-623

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Raf kinase cascade in cancer therapy – novel molecular targets and therapeutic strategies

By Jr John T Lee   McCubrey James A  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 6, 2002-12 ,pp. : 659-678

Informa Healthcare

Access to resources Recommend Favorite

Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 217-235

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting RAS Signaling Pathways in Juvenile Myelomonocytic Leukemia

By  

Current Drug Targets, Vol. 8, Iss. 6, 2007-06 ,pp. : 715-725

Bentham Science Publishers

Access to resources Recommend Favorite